Advertisement
Abstract only| Volume 16, ISSUE 3, SUPPLEMENT , S79-S80, May 01, 2017

High Dose-Rate Tandem and Ovoid Brachytherapy in Cervical Cancer: Dosimetric Predictors of Disease Control and Toxicity

DOI:https://doi.org/10.1016/j.brachy.2017.04.145
High Dose-Rate Tandem and Ovoid Brachytherapy in Cervical Cancer: Dosimetric Predictors of Disease Control and Toxicity
Previous ArticleFeasibility of a Biomechanical Model Based Deformable Image Registration for MRI Guided CT-Based Brachytherapy for Locally Advanced Cervical Cancer
Next ArticleInvestigation of a New Device to Improve Dosimetric Outcomes in Intravascular Brachytherapy
      To investigate the rate of and factors influencing gastrointestinal (GI) and genitourinary (GU) toxicity following high dose-rate (HDR) tandem and ovoid brachytherapy in the treatment of locally advanced cervical cancer.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Brachytherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      Article Info

      Publication History

      PO34

      Identification

      DOI: https://doi.org/10.1016/j.brachy.2017.04.145

      Copyright

      © 2017 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2022 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX